AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
4.000
0.00 (0.00%)
Nov 9, 2026, 4:00 PM EST - Market closed
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $151.77 million as of November 9, 2026. It is the 22,274th most valuable company in the world and the 3,767th biggest in the United States. Its market cap has increased by 387.21% in one year.
Market Cap
151.77M
Enterprise Value
87.37M
1-Year Change
387.21%
Global Rank
Country Rank
#3,767 United States
Category
ChartMarket Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $151.77M, a decrease of -46.01%. That is a compound annual growth rate of -12.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 151.77M | 385.86% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 163.56M |
| Zentalis Pharmaceuticals | 162.84M |
| Oramed Pharmaceuticals | 160.57M |
| ALX Oncology Holdings | 159.71M |
| Sutro Biopharma | 159.51M |
| Satellos Bioscience | 152.30M |
| MacroGenics | 148.42M |
| Sionna Therapeutics | 148.30M |